| Dr Tauqir X Ahmed, MD | |
|
12266 Depaul Dr., Suite 305, Bridgeton, MO 63044-2516 | |
| (314) 770-0991 | |
| (314) 770-0692 |
| Full Name | Dr Tauqir X Ahmed |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 30 Years |
| Location | 12266 Depaul Dr., Bridgeton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336252204 | NPI | - | NPPES |
| 205156706 | Medicaid | MO | |
| P00216682 | Other | MO | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2000160608 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| Ssm St Joseph Health Center | Saint charles, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Medical Group Inc | 6608776299 | 491 |
News Archive
Anxiety disorders affect one in five youth. Generally, a child is treated with either cognitive behavioral therapy (CBT) or medication. But despite the high prevalence of anxiety, there is no study-based evidence to compare the success rate of medication versus CBT.
Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.
Every year in the United States, about 800,000 people experience a stroke. Many are left with neurological complications such as paralysis on one side of the body, speech and language problems, vision issues, behavioral changes, and memory loss.
Microglia are the cells responsible for immune surveillance in the brain, and they initiate protective inflammatory reactions in response to tissue damage and infection. An international team under the leadership of LMU neuroscientist Professor Jochen Herms has now shown that these cells may actually make a significant contribution to the loss of neurons associated with Alzheimer's disease.
In recent years, an effort has been underway to redefine malnutrition in pediatric patients to include both the acute clinical population and the more traditional ambulatory populations. Identifying and treating malnutrition in pediatric patients is important from an acute standpoint and to ensure that children have enough nutrition to reach optimal final height and development.
› Verified 7 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
Anxiety disorders affect one in five youth. Generally, a child is treated with either cognitive behavioral therapy (CBT) or medication. But despite the high prevalence of anxiety, there is no study-based evidence to compare the success rate of medication versus CBT.
Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.
Every year in the United States, about 800,000 people experience a stroke. Many are left with neurological complications such as paralysis on one side of the body, speech and language problems, vision issues, behavioral changes, and memory loss.
Microglia are the cells responsible for immune surveillance in the brain, and they initiate protective inflammatory reactions in response to tissue damage and infection. An international team under the leadership of LMU neuroscientist Professor Jochen Herms has now shown that these cells may actually make a significant contribution to the loss of neurons associated with Alzheimer's disease.
In recent years, an effort has been underway to redefine malnutrition in pediatric patients to include both the acute clinical population and the more traditional ambulatory populations. Identifying and treating malnutrition in pediatric patients is important from an acute standpoint and to ensure that children have enough nutrition to reach optimal final height and development.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tauqir X Ahmed, MD Po Box 955534, Saint Louis, MO 63195-5534 Ph: () - | Dr Tauqir X Ahmed, MD 12266 Depaul Dr., Suite 305, Bridgeton, MO 63044-2516 Ph: (314) 770-0991 |
News Archive
Anxiety disorders affect one in five youth. Generally, a child is treated with either cognitive behavioral therapy (CBT) or medication. But despite the high prevalence of anxiety, there is no study-based evidence to compare the success rate of medication versus CBT.
Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.
Every year in the United States, about 800,000 people experience a stroke. Many are left with neurological complications such as paralysis on one side of the body, speech and language problems, vision issues, behavioral changes, and memory loss.
Microglia are the cells responsible for immune surveillance in the brain, and they initiate protective inflammatory reactions in response to tissue damage and infection. An international team under the leadership of LMU neuroscientist Professor Jochen Herms has now shown that these cells may actually make a significant contribution to the loss of neurons associated with Alzheimer's disease.
In recent years, an effort has been underway to redefine malnutrition in pediatric patients to include both the acute clinical population and the more traditional ambulatory populations. Identifying and treating malnutrition in pediatric patients is important from an acute standpoint and to ensure that children have enough nutrition to reach optimal final height and development.
› Verified 7 days ago
Dr. Kyle Christensen, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 12266 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-770-0991 | |
Dr. Mohammad Ali Javed, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 12303 De Paul Dr, Bridgeton, MO 63044 Phone: 314-344-6000 | |
Dr. Joshua Stuart Glaser, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 12266 Depaul Dr, Suite 305, Bridgeton, MO 63044 Phone: 314-770-0991 Fax: 317-770-0692 | |
Dr. Jack Roh Oak, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 12266 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-770-0991 | |
Alan M Yahanda, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3440 De Paul Ln Ste 110a, Bridgeton, MO 63044 Phone: 314-209-5225 | |
Dr. Andrea Maria Zelisko Schwoerer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 12266 Depaul Drive, Suite 210, Bridgeton, MO 63044 Phone: 314-344-6800 |